Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-109133
Filing Date
2024-09-24
Accepted
2024-09-24 17:26:24
Documents
1
Period of Report
2024-09-23

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4105
  Complete submission text file 0000950170-24-109133.txt   5541
Mailing Address C/O SIERRA ONCOLOGY, INC. 1820 GATEWAY DRIVE, SUITE 110 SAN MATEO CA 94404
Business Address
Klencke Barbara (Reporting) CIK: 0001647647 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40603 | Film No.: 241320937

Mailing Address 880 WINTER STREET WALTHAM MA 02451
Business Address 880 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Issuer) CIK: 0001783328 (see all company filings)

EIN.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)